4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001673232-26-000004
PRESIDENT AND COO sold 14,625 shares at an average $487.38 ($7,127,877)
- PRESIDENT AND COO acquired 14,625 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BENKOWITZ MICHAEL PRESIDENT AND COO | 2026-01-05 | Option exercise 10b5-1 | +14,625 | $117.76 | $1,722,240 | 14,625 | I: show line 1 in the form |
| BENKOWITZ MICHAEL PRESIDENT AND COO | 2026-01-05 | Sale 10b5-1 | −697 | $480.68 | $335,035 | 13,928 | I: show line 2 in the form |
| BENKOWITZ MICHAEL PRESIDENT AND COO | 2026-01-05 | Sale 10b5-1 | −1,657 | $481.86 | $798,446 | 12,271 | I: show line 3 in the form |
| BENKOWITZ MICHAEL PRESIDENT AND COO | 2026-01-05 | Sale 10b5-1 | −873 | $482.72 | $421,414 | 11,398 | I: show line 4 in the form |
| BENKOWITZ MICHAEL PRESIDENT AND COO | 2026-01-05 | Sale 10b5-1 | −697 | $483.80 | $337,212 | 10,701 | I: show line 5 in the form |
| BENKOWITZ MICHAEL PRESIDENT AND COO | 2026-01-05 | Sale 10b5-1 | −1,169 | $485.00 | $566,959 | 9,532 | I: show line 6 in the form |
| BENKOWITZ MICHAEL PRESIDENT AND COO | 2026-01-05 | Sale 10b5-1 | −1,669 | $486.05 | $811,217 | 7,863 | I: show line 7 in the form |
| BENKOWITZ MICHAEL PRESIDENT AND COO | 2026-01-05 | Sale 10b5-1 | −856 | $487.40 | $417,218 | 7,007 | I: show line 8 in the form |
| Open-market sales · 14,625 sh · avg $487.38 · $7,127,877 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BENKOWITZ MICHAEL PRESIDENT AND COO | 2026-01-05 | Option exercise · Stock Options 10b5-1 | −14,625 | 97,125 | I: show line 16 in the form |
Loading xslF345X05/primarydocument.xml…